Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2018 Filed Mar 5, 2018 20:48 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
GrantOptions To Purchase Common Stock · Derivative | 27,000 | $0.00 Strike: $59.96 | $0.00 |
DisclosureSEC source: 0001127602-18-010000 · form4.xml · derivative · entry 7 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,000 Underlying: Common Stock · 27,000 shares Expires 2028-03-01 F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:48 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 350 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010000 · form4.xml · derivative · entry 6 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700 Underlying: Common Stock · 350 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:48 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,025 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010000 · form4.xml · derivative · entry 5 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,025 Underlying: Common Stock · 1,025 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:48 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Tax withholdingCommon Stock | 116 | $59.96 | $6,955.36 |
DisclosureSEC source: 0001127602-18-010000 · form4.xml · nonDerivative · entry 4 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,381 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:48 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Exercise / conversionCommon Stock | 350 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010000 · form4.xml · nonDerivative · entry 3 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:48 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Tax withholdingCommon Stock | 352 | $59.96 | $21,105.92 |
DisclosureSEC source: 0001127602-18-010000 · form4.xml · nonDerivative · entry 2 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,147 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:48 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Exercise / conversionCommon Stock | 1,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010000 · form4.xml · nonDerivative · entry 1 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,499 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:43 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
GrantOptions To Purchase Common Stock · Derivative | 32,000 | $0.00 Strike: $59.96 | $0.00 |
DisclosureSEC source: 0001127602-18-009997 · form4.xml · derivative · entry 7 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2028-03-01 F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:43 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 400 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-009997 · form4.xml · derivative · entry 6 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 Underlying: Common Stock · 400 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:43 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 425 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-009997 · form4.xml · derivative · entry 5 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 850 Underlying: Common Stock · 425 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:43 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Tax withholdingCommon Stock | 119 | $59.96 | $7,135.24 |
DisclosureSEC source: 0001127602-18-009997 · form4.xml · nonDerivative · entry 4 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,950 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:43 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Exercise / conversionCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-009997 · form4.xml · nonDerivative · entry 3 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,069 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:43 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Tax withholdingCommon Stock | 127 | $59.96 | $7,614.92 |
DisclosureSEC source: 0001127602-18-009997 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,669 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:43 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Exercise / conversionCommon Stock | 425 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-009997 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,796 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:34 UTC |
Hartman Curt RDirector · President & CEO
|
GrantOptions To Purchase Common Stock · Derivative | 175,000 | $0.00 Strike: $59.96 | $0.00 |
DisclosureSEC source: 0001127602-18-009990 · form4.xml · derivative · entry 7 Hartman Curt R · CIK 0001451535 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2028-03-01 F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:34 UTC |
Hartman Curt RDirector · President & CEO
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 2,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-009990 · form4.xml · derivative · entry 6 Hartman Curt R · CIK 0001451535 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,500 Underlying: Common Stock · 2,250 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:34 UTC |
Hartman Curt RDirector · President & CEO
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,950 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-009990 · form4.xml · derivative · entry 5 Hartman Curt R · CIK 0001451535 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,950 Underlying: Common Stock · 1,950 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2006 Stock Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:34 UTC |
Hartman Curt RDirector · President & CEO
|
Tax withholdingCommon Stock | 644 | $59.96 | $38,614.24 |
DisclosureSEC source: 0001127602-18-009990 · form4.xml · nonDerivative · entry 4 Hartman Curt R · CIK 0001451535 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,504 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:34 UTC |
Hartman Curt RDirector · President & CEO
|
Exercise / conversionCommon Stock | 2,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-009990 · form4.xml · nonDerivative · entry 3 Hartman Curt R · CIK 0001451535 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,148 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:34 UTC |
Hartman Curt RDirector · President & CEO
|
Tax withholdingCommon Stock | 552 | $59.96 | $33,097.92 |
DisclosureSEC source: 0001127602-18-009990 · form4.xml · nonDerivative · entry 2 Hartman Curt R · CIK 0001451535 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,898 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:34 UTC |
Hartman Curt RDirector · President & CEO
|
Exercise / conversionCommon Stock | 1,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-009990 · form4.xml · nonDerivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2018 Filed Feb 13, 2018 21:54 UTC |
POMILIO LUKE AAdvisor to CFO
|
SaleCommon Stock | 1,962 | $60.25 | $118,210.50 |
DisclosureSEC source: 0001127602-18-005546 · form4.xml · nonDerivative · entry 1 POMILIO LUKE A · CIK 0001238337 · Advisor to CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 02, 2018 Filed Feb 5, 2018 19:03 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 2,000 | $0.00 Strike: $32.93 | $0.00 |
DisclosureSEC source: 0001127602-18-003918 · form4.xml · derivative · entry 3 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2023-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| February 02, 2018 Filed Feb 5, 2018 19:03 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Tax withholdingCommon Stock | 1,419 | $63.21 | $89,694.99 |
DisclosureSEC source: 0001127602-18-003918 · form4.xml · nonDerivative · entry 2 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,474 Read SEC document |
| February 02, 2018 Filed Feb 5, 2018 19:03 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Exercise / conversionCommon Stock | 2,000 | $32.93 | $65,860.00 |
DisclosureSEC source: 0001127602-18-003918 · form4.xml · nonDerivative · entry 1 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,893 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 20:42 UTC |
GOLDEN JO ANNDirector
|
SaleCommon Stock | 3,000 | $63.90 | $191,694.00 |
DisclosureSEC source: 0001127602-18-003616 · form4.xml · nonDerivative · entry 1 GOLDEN JO ANN · CIK 0001238330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,782 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.88 to $63.94. Full information regarding the number of shares sold at each price will be provided upon request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 20:18 UTC |
Cohen Heather LEVP CORP HR
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 2,000 | $0.00 Strike: $16.46 | $0.00 |
DisclosureSEC source: 0001127602-18-003604 · form4.xml · derivative · entry 3 Cohen Heather L · CIK 0001436649 · EVP CORP HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2019-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 20:18 UTC |
Cohen Heather LEVP CORP HR
|
Tax withholdingCommon Stock | 1,101 | $63.35 | $69,748.35 |
DisclosureSEC source: 0001127602-18-003604 · form4.xml · nonDerivative · entry 2 Cohen Heather L · CIK 0001436649 · EVP CORP HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,525 Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 20:18 UTC |
Cohen Heather LEVP CORP HR
|
Exercise / conversionCommon Stock | 2,000 | $16.46 | $32,920.00 |
DisclosureSEC source: 0001127602-18-003604 · form4.xml · nonDerivative · entry 1 Cohen Heather L · CIK 0001436649 · EVP CORP HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,626 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 19:01 UTC |
POMILIO LUKE AAdvisor to CFO
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 18,400 | $0.00 Strike: $51.30 | $0.00 |
DisclosureSEC source: 0001127602-18-003917 · form4.xml · derivative · entry 4 POMILIO LUKE A · CIK 0001238337 · Advisor to CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,600 Underlying: Common Stock · 18,400 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (20%) over a five year period. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 19:01 UTC |
POMILIO LUKE AAdvisor to CFO
|
Tax withholdingCommon Stock | 16,438 | $63.35 | $1,041,347.30 |
DisclosureSEC source: 0001127602-18-003917 · form4.xml · nonDerivative · entry 3 POMILIO LUKE A · CIK 0001238337 · Advisor to CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,962 Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 19:01 UTC |
POMILIO LUKE AAdvisor to CFO
|
Exercise / conversionCommon Stock | 18,400 | $51.30 | $943,920.00 |
DisclosureSEC source: 0001127602-18-003917 · form4.xml · nonDerivative · entry 2 POMILIO LUKE A · CIK 0001238337 · Advisor to CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 19:01 UTC |
POMILIO LUKE AAdvisor to CFO
|
SaleCommon Stock | 18,023 | $63.38 | $1,142,229.25 |
DisclosureSEC source: 0001127602-18-003917 · form4.xml · nonDerivative · entry 1 POMILIO LUKE A · CIK 0001238337 · Advisor to CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.00 to $63.88. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| January 03, 2018 Filed Jan 4, 2018 18:31 UTC |
Farkas CharlesDirector
|
PurchaseCommon Stock | 158 | $50.61 | $7,996.38 |
DisclosureSEC source: 0001127602-18-000983 · form4.xml · nonDerivative · entry 1 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,707 F1 · shares: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 27, 2017. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 17:39 UTC |
Garner Todd WExecutive Vice President & CFO
|
GrantRsus (restricted Stock Units) · Derivative | 8,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-000975 · form4.xml · derivative · entry 2 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2028-01-02 F2 · derivative.exercise_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.001 per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (25%) over a four year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 17:39 UTC |
Garner Todd WExecutive Vice President & CFO
|
GrantOptions To Purchase Common Stock · Derivative | 48,000 | $0.00 Strike: $50.61 | $0.00 |
DisclosureSEC source: 0001127602-18-000975 · form4.xml · derivative · entry 1 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 Underlying: Common Stock · 48,000 shares Expires 2028-01-02 F1 · derivative.exercise_date: Each Stock Option represents a contingent right to receive one share of common stock, par value $0.001, per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (20%) over a five year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018. Read SEC document |
| December 31, 2017 Filed Feb 13, 2018 16:11 UTC |
Cohen Heather LEVP CORP HR
|
Other401 (K) Plan | 20.9974 | $50.97 | $1,070.24 |
DisclosureSEC source: 0001127602-18-005353 · form5.xml · nonDerivative · entry 1 Cohen Heather L · CIK 0001436649 · EVP CORP HR 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (K) Plan Disclosed balance after: 4,846.005 F1 · date: As of December 31, 2017. F2 · kind: No change in holdings other than as a result of value of stock in the Conmed 401(K) plan. F3 · shares: The 20.9974 represents an approximate number of shares equivalent in a Company stock fund in the 401 (K) Plan. Read SEC document |
| December 31, 2017 Filed Feb 14, 2018 20:42 UTC |
Berge Terence MVP Corp. Treasurer
|
Other401 (K) Plan | 1,294.8792 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-006069 · form5.xml · nonDerivative · entry 1 Berge Terence M · CIK 0001635424 · VP Corp. Treasurer 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (K) Plan Disclosed balance after: 0 F1 · date: As of December 31, 2017. F2 · kind: All shares exchanged out of the Conmed 401(K) Plan. There is no impact on outright ownership of Conmed stock. F3 · shares: The 1,294.8792 shares equivalent in a Company stock fund in the 401(K) Plan have all been exchanged out. Read SEC document |
| December 29, 2017 Filed Jan 2, 2018 17:33 UTC |
Ruiz-Caban WilfredoEVP QA, RA and Operations
|
GrantCommon Stock | 33 | $48.42 | $1,597.86 |
DisclosureSEC source: 0001127602-18-000042 · form4.xml · nonDerivative · entry 1 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298 Read SEC document |
| December 29, 2017 Filed Jan 2, 2018 17:26 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
GrantCommon Stock | 87 | $48.42 | $4,212.54 |
DisclosureSEC source: 0001127602-18-000040 · form4.xml · nonDerivative · entry 1 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,893 Read SEC document |
| December 01, 2017 Filed Dec 4, 2017 20:40 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
GiftCommon Stock | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-033778 · form4.xml · nonDerivative · entry 2 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,806 Read SEC document |
| December 01, 2017 Filed Dec 4, 2017 20:40 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
GiftCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-033778 · form4.xml · nonDerivative · entry 1 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,856 Read SEC document |
| November 09, 2017 Filed Nov 9, 2017 21:18 UTC |
POMILIO LUKE AEVP, Finance & CFO
|
SaleCommon Stock | 4,000 | $50.70 | $202,800.00 |
DisclosureSEC source: 0001127602-17-031737 · form4.xml · nonDerivative · entry 4 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,023 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.65 to $50.75. Full information regarding the number of shares sold at each separate price will be provided upon the request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 21:18 UTC |
POMILIO LUKE AEVP, Finance & CFO
|
SaleCommon Stock | 12,934 | $50.77 | $656,659.18 |
DisclosureSEC source: 0001127602-17-031737 · form4.xml · nonDerivative · entry 3 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,023 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.54 to $51.14. Full information regarding the number of shares sold at each separate price will be provided upon the request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| November 07, 2017 Filed Nov 9, 2017 21:18 UTC |
POMILIO LUKE AEVP, Finance & CFO
|
SaleCommon Stock | 10,529 | $50.60 | $532,767.40 |
DisclosureSEC source: 0001127602-17-031737 · form4.xml · nonDerivative · entry 2 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,957 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.50 to $50.72. Full information regarding the number of shares sold at each separate price will be provided upon the request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| November 07, 2017 Filed Nov 9, 2017 21:18 UTC |
POMILIO LUKE AEVP, Finance & CFO
|
SaleCommon Stock | 1,900 | $50.82 | $96,558.00 |
DisclosureSEC source: 0001127602-17-031737 · form4.xml · nonDerivative · entry 1 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,486 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.59 to $50.99. Full information regarding the number of shares sold at each separate price will be provided upon the request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 17:32 UTC |
POMILIO LUKE AEVP, Finance & CFO
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 4,680 | $0.00 Strike: $44.90 | $0.00 |
DisclosureSEC source: 0001127602-17-031437 · form4.xml · derivative · entry 21 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,120 Underlying: Common Stock · 4,680 shares Expires 2024-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 17:32 UTC |
POMILIO LUKE AEVP, Finance & CFO
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 9,600 | $0.00 Strike: $32.93 | $0.00 |
DisclosureSEC source: 0001127602-17-031437 · form4.xml · derivative · entry 20 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,400 Underlying: Common Stock · 9,600 shares Expires 2023-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 17:32 UTC |
POMILIO LUKE AEVP, Finance & CFO
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 10,000 | $0.00 Strike: $26.09 | $0.00 |
DisclosureSEC source: 0001127602-17-031437 · form4.xml · derivative · entry 19 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2022-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 17:32 UTC |
POMILIO LUKE AEVP, Finance & CFO
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 10,000 | $0.00 Strike: $27.63 | $0.00 |
DisclosureSEC source: 0001127602-17-031437 · form4.xml · derivative · entry 18 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2021-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.